SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001410939-22-000012
Filing Date
2022-02-24
Accepted
2022-02-24 06:40:02
Documents
14
Period of Report
2022-02-24
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K isee-20220224.htm   iXBRL 8-K 35549
2 EX-99.1 isee4qqye2021pressreleasef.htm EX-99.1 81124
6 image_0.jpg GRAPHIC 14302
  Complete submission text file 0001410939-22-000012.txt   284422

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT isee-20220224.xsd EX-101.SCH 1927
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT isee-20220224_lab.xml EX-101.LAB 24229
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT isee-20220224_pre.xml EX-101.PRE 12617
8 EXTRACTED XBRL INSTANCE DOCUMENT isee-20220224_htm.xml XML 10557
Mailing Address 8 SYLVAN WAY PARSIPPANY NJ 07054
Business Address 8 SYLVAN WAY PARSIPPANY NJ 07054 (609) 474-6755
IVERIC bio, Inc. (Filer) CIK: 0001410939 (see all company filings)

IRS No.: 208185347 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36080 | Film No.: 22666408
SIC: 2834 Pharmaceutical Preparations